Novel 5-(benzyloxy)pyridin-2(1H)-one derivatives as potent c-Met inhibitors

被引：7

作者：

Zhang, Dengyou ^{[1
]}

Ai, Jing ^{[2
]}

Liang, Zhongjie ^{[3
]}

Zhu, Wei ^{[1
]}

Peng, Xia ^{[2
]}

Chen, Xianjie ^{[1
]}

Ji, YinChun ^{[2
]}

Jiang, Hualiang ^{[1
,4
]}

Luo, Cheng ^{[1
]}

Geng, Meiyu ^{[2
]}

Liu, Hong ^{[1
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, State Key Lab Drug Res,CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China

[3] Soochow Univ, Ctr Syst Biol, Suzhou 215006, Jiangsu, Peoples R China

[4] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 08期

基金：

中国国家自然科学基金;

关键词：

c-Met; EBC-1; cell; Tyrosine kinase receptor; KINASE INHIBITORS; DISCOVERY;

D O I：

10.1016/j.bmcl.2013.02.037

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel 5-(benzyloxy)pyridin-2(1H)-ones were designed, synthesized and biologically evaluated for c-Met inhibition. Various amides and benzoimidazoles at C-3 position were investigated. A potent compound 12b with a c-Met IC50 of 12 nM was identified. This compound exhibited potent inhibition of EBC-1 cell associated with c-Met constitutive activation and showed high selectivity for c-Met than other tested 11 kinases. The binding model 12b with c-Met was disclosed by docking analysis. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：2408 / 2413

页数：6

共 12 条

[1] Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK) [J].

Cui, J. Jean ;

Tran-Dube, Michelle ;

Shen, Hong ;

Nambu, Mitchell ;

Kung, Pei-Pei ;

Pairish, Mason ;

Jia, Lei ;

Meng, Jerry ;

Funk, Lee ;

Botrous, Iriny ;

McTigue, Michele ;

Grodsky, Neil ;

Ryan, Kevin ;

Padrique, Ellen ;

Alton, Gordon ;

Timofeevski, Sergei ;

Yamazaki, Shinji ;

Li, Quhua ;

Zou, Helen ;

Christensen, James ;

Mroczkowski, Barbara ;

Bender, Steve ;

Kania, Robert S. ;

Edwards, Martin P. .

JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (18) :6342-6363

[2] Fit-for-Purpose Development of the Enabling Route to Crizotinib (PF-02341066) [J].

de Koning, Pieter D. ;

McAndrew, Douglas ;

Moore, Robert ;

Moses, Ian B. ;

Boyles, David C. ;

Kissick, Kyle ;

Stanchina, Corey L. ;

Cuthbertson, Timothy ;

Kamatani, Asayuki ;

Rahman, Leera ;

Rodriguez, Rick ;

Urbina, Armando ;

Sandoval, Alison ;

Rose, Peter R. .

ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (05) :1018-1026

[3] Targeting MET in cancer: rationale and progress [J].

Gherardi, Ermanno ;

Birchmeier, Walter ;

Birchmeier, Carmen ;

Woude, George Vande .

NATURE REVIEWS CANCER, 2012, 12 (02) :89-103

[4] Synthesis and Biological Evaluation of Botulinum Neurotoxin A Protease Inhibitors [J].

Li, Bing ;

Pai, Ramdas ;

Cardinale, Steven C. ;

Butler, Michelle M. ;

Peet, Norton P. ;

Moir, Donald T. ;

Bavari, Sina ;

Bowlin, Terry L. .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) :2264-2276

[5]

Liang C, 2009, Patent Application Date, Patent No. [WO 2009/154769 A1, 2009154769, WO2009154769]

[6] Development of c-MET pathway inhibitors [J].

Liu, Xiangdong ;

Newton, Robert C. ;

Scherle, Peggy A. .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (09) :1225-1241

[7] Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors [J].

Lovly, Christine M. ;

Heuckmann, Johannes M. ;

de Stanchina, Elisa ;

Chen, Heidi ;

Thomas, Roman K. ;

Liang, Chris ;

Pao, William .

CANCER RESEARCH, 2011, 71 (14) :4920-4931

[8] A Simple Cu-Catalyzed Coupling Approach to Substituted 3-Pyridinol and 5-Pyrimidinol Antioxidants [J].

Nara, Susheel J. ;

Jha, Mukund ;

Brinkhorst, Johan ;

Zemanek, Tony J. ;

Pratt, Derek A. .

JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (23) :9326-9333

[9]

Nemecek C., 2009, WO, Patent No. [2009087305, WO 2009087305-A1]

[10] Discovery of 6-benzyloxyquinolines as c-Met selective kinase inhibitors [J].

Nishii, Hiroki ;

Chiba, Takashi ;

Morikami, Kenji ;

Fukami, Takaaki A. ;

Sakamoto, Hiroshi ;

Ko, Kwangseok ;

Koyano, Hiroshi .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (04) :1405-1409

← 1 2 →